TNFRSF1B and autoimmune disease: The development of TNFR2 agonists is introduced and the effect of these agents on the activation of different subsets of immune cells, and factors that may determine the therapeutic outcome of TNFR2 agonists in the treatment of cancer or autoimmune diseases, are reviewed and analyzed.